Copenhagen, Denmark, 27 September 2022 - Xellia Pharmaceuticals (‘Xellia’), a global leader in the manufacturing of specialty anti-infective treatments and other critical care therapies for serious and often life-threatening conditions, announces that it has become a member of the Pharmaceutical Supply Chain Initiative (PSCI).
The PSCI is a membership group of companies in the pharmaceutical and healthcare sector that commit to working together towards a common vision of excellence in pharmaceutical supply chains1. With member companies brought together under the common principles of the PSCI for Responsible Supply Chain Management; the members pledge to address and uphold responsible business practices within the areas of human rights, environmental sustainability, and responsible business practices. Through a commitment to adhering to the incorporation of the PSCI principles of ethics, human rights and labor, health and safety, environment, and management systems; the organization enables a forum where members are able to promote pharmaceutical supply chain excellence through collectively working on defining and establishing community agendas, providing a platform for knowledge sharing, and for advocating for responsible supply chains2.
As expressed by Xellia Pharmaceutical’s Senior Vice President, Quality EHS and Sustainability, Geelanie Briones “At Xellia, we aspire to be a sustainable business that adds value to society and actively partners with key stakeholders in addressing global challenges. By being a PSCI member, Xellia endorses and shares the PSCI vision, purpose and principles – Xellia commits to promoting responsible supply chain practices, that will continuously improve ethics, labor, health, safety and environmentally sustainable outcomes in supply chain management. We aim to be part of driving complex global changes as we join the PSCI community, where we can share knowledge and expertise, and be guided with the same principles and purpose.”
In line with Xellia’s commitment towards continuous focus on its sustainability efforts, Xellia is proud to join PSCI, and appreciate the network of members from the industry working together to promote and strengthen practices for responsible supply chains.
About the Pharmaceutical Supply Chain Initiative (PSCI)3
The PSCI is a membership group of companies in the pharmaceutical and healthcare sector that commit to working together towards a common vision of excellence in our supply chains. The PSCI’s vision is for excellence in safety, environmental, and social outcomes across the whole of the global pharmaceutical and healthcare supply chain. The foundational commitment of all members is to the PSCI Principles. They are our blueprint for responsible practice, setting out our expectations for five relevant topic areas.
Members of PSCI are to integrate the principles into their own supplier codes and uphold them in their operations, aiming for continual improvement by advancing supplier performance over time.
To learn more about PSCI visit: - PSCI (pscinitiative.org)
1 PSCI (pscinitiative.org)
2 PSCI (pscinitiative.org)
3 PSCI (pscinitiative.org)